Multi-omics approaches for deciphering disease evolution and identifying therapeutic targets in acute myeloid leukemia
Recent advances in multi-omics technologies are summarized and how integrative analyses are reshaping the understanding of AML evolution are discussed, which highlights emerging therapeutic targets identified through multi-omics investigations and examines their translational potential for innovative drug development.